Conclusion
embolism, device-detected, stroke, ischemic stroke
EMBOLISM, STROKE, ISCHEMIC STROKE
Despite participation in an intensively managed RM system with in-built cues for consideration of anticoagulation, more than 30% of patients with device-detected AF were not anticoagulated in the presence of a risk factor profile inferring a significant risk of ischemic stroke or systemic embolism. Older patients, aged 75 or above, were under-anticoagulated compared with their younger counterparts. These data represent potential missed opportunities to implement pharmacotherapy for stroke prevention. Improved RM clinical response pathways are required to ensure adherence to stroke prevention measures in the device-detected AF population.